 Recombinant Proteins
"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1986 | 0 | 2 | 2 | | 1987 | 3 | 3 | 6 | | 1988 | 1 | 6 | 7 | | 1989 | 0 | 4 | 4 | | 1990 | 0 | 6 | 6 | | 1991 | 0 | 6 | 6 | | 1992 | 0 | 12 | 12 | | 1993 | 0 | 15 | 15 | | 1994 | 0 | 18 | 18 | | 1995 | 0 | 19 | 19 | | 1996 | 0 | 20 | 20 | | 1997 | 0 | 9 | 9 | | 1998 | 0 | 15 | 15 | | 1999 | 0 | 20 | 20 | | 2000 | 0 | 13 | 13 | | 2001 | 1 | 14 | 15 | | 2002 | 1 | 22 | 23 | | 2003 | 3 | 35 | 38 | | 2004 | 3 | 32 | 35 | | 2005 | 1 | 23 | 24 | | 2006 | 0 | 19 | 19 | | 2007 | 2 | 26 | 28 | | 2008 | 0 | 34 | 34 | | 2009 | 6 | 18 | 24 | | 2010 | 0 | 21 | 21 | | 2011 | 3 | 17 | 20 | | 2012 | 2 | 20 | 22 | | 2013 | 1 | 11 | 12 | | 2014 | 1 | 14 | 15 | | 2015 | 3 | 9 | 12 | | 2016 | 0 | 2 | 2 | | 2017 | 2 | 1 | 3 | | 2018 | 0 | 2 | 2 | | 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Santos ARRD, Serufo ÂV, Figueiredo MM, Godoi LC, Vitório JG, Marcelino AP, Avelar DM, Rodrigues FTG, Machado-Coelho GLL, Medeiros FAC, Jerônimo SMB, Oliveira EJ, Nascimento FC, Teixeira SMR, Gazzinelli RT, Nagem RAP, Fernandes AP. Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis. Mem Inst Oswaldo Cruz. 2019 Feb 04; 114:e180405.
-
Yu WH, Zhao P, Draghi M, Arevalo C, Karsten CB, Suscovich TJ, Gunn B, Streeck H, Brass AL, Tiemeyer M, Seaman M, Mascola JR, Wells L, Lauffenburger DA, Alter G. Exploiting glycan topography for computational design of Env glycoprotein antigenicity. PLoS Comput Biol. 2018 04; 14(4):e1006093.
-
Morger D, Zosel F, Bühlmann M, Züger S, Mittelviefhaus M, Schuler B, Luban J, Grütter MG. The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5a. J Virol. 2018 03 01; 92(5).
-
Padilla-Benavides T, Nasipak BT, Paskavitz AL, Haokip DT, Schnabl JM, Nickerson JA, Imbalzano AN. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition. J Biol Chem. 2017 11 10; 292(45):18592-18607.
-
Huang Z, Lee DY, Yoon S. Quantitative intracellular flux modeling and applications in biotherapeutic development and production using CHO cell cultures. Biotechnol Bioeng. 2017 12; 114(12):2717-2728.
-
Krishnan B, Hedstrom L, Hebert DN, Gierasch LM, Gershenson A. Expression and Purification of Active Recombinant Human Alpha-1 Antitrypsin (AAT) from Escherichia coli. Methods Mol Biol. 2017; 1639:195-209.
-
Carandang RA. Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy. JAMA Neurol. 2016 Mar; 73(3):265-7.
-
Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B, Thompson PR, Fillipakopoulos P, Knapp S, Venables PJ, La Thangue NB. Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Sci Adv. 2016 Feb; 2(2):e1501257.
-
Mun JY, Kensler RW, Harris SP, Craig R. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol. 2016 Feb; 91:141-7.
-
Durmaz E, Hu Y, Aroian RV, Klaenhammer TR. Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic. Appl Environ Microbiol. 2015 Dec 18; 82(4):1286-94.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|